Evidence map›Paper›PMID 28733685›Full record

ArticleScientific reports2017

Trypanosoma brucei growth control by TNF in mammalian host is independent of the soluble form of the cytokine.

Gilles Vanwalleghem, Yannick Morias, Alain Beschin, David E Szymkowski, Etienne Pays

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Adenylate Cyclases ofPathogens (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Gilles VanwalleghemLaboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, Gosselies, Belgium. g.vanwalleghem@uq.edu.au.ORCID 0000-0002-6188-9582
Yannick MoriasLaboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Alain BeschinLaboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
David E SzymkowskiXencor Inc., Monrovia, California, U.S.A.ORCID 0000-0002-8934-7902
Etienne PaysLaboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, Gosselies, Belgium.
Université Libre de Bruxelles · BEVrije Universiteit Brussel · BEXencor (United States) · US

Funding

European Research Council 669007
6 · The paper itself

Abstract

Infection of C57Bl/6 mice by pleomorphic African trypanosomes Trypanosoma brucei and T. congolense is characterized by parasitemia waves coupled with the production of systemic levels of TNF. This cytokine is known to control T. brucei growth, but also to contribute to tissue damage, shortening the survival time of infected mice. Using a dominant-negative version of TNF to discriminate between the effects of the membrane-form versus the soluble form of TNF, we show that the second form is involved in neither parasite control nor induction of liver injury. Therefore, soluble TNF is likely not a major contributor to disease outcome. We propose that membrane-bound TNF is responsible for both T. brucei control and host pathology.

Indexed as

AnimalsCell MembraneMiceMice, Inbred C57BLParasitemiaReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITrypanosoma brucei bruceiTrypanosomiasis, AfricanTumor Necrosis Factor-alphaReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITnfrsf1a protein, mouseTumor Necrosis Factor-alphaXENP 1595

Identifiers

PMID28733685
PMCPMC5522424
OpenAlexW2735627295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.